Home › Zacks Investment Research Upgrades Medifast Inc (MED) to Buy
 

Keywords :   


Zacks Investment Research Upgrades Medifast Inc (MED) to Buy

2016-04-12 22:33:55| Biotech - Topix.net

The firm currently has $33.00 target price on the stock. According to Zacks, "Medifast Inc has one operating subsidiary, Jason Pharmaceuticals, Inc, its manufacturing arm.

Tags: buy research med investment

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05New ACA-Published Industry Market Analysis for the Paint & Coatings Industry Now Available
20.05Ulta Beauty Launches Same-Day Delivery with DoorDash
20.05Nivea Crmes Limited-Edition Pride Tin Heralds New Initiative with PFLAG
20.05Sheboygan Paint Company Appoints New Technical Sales Representative
20.05Scentair Adds Two Odor-Neutralizing Fragrances to its Auto Line Up
20.05GK Hair Unveils Summer 2024s Must-Have Hair Trends
20.05Revlon Taps Under Armour\'s Tchernavia Rocker As New Chief People Officer
20.05Canada invests over $9.6M to prevent, prepare for African swine fever
More »